Table 1. Baseline sociodemographic characteristics and clinical overview.

	Overall (N = 686)
age
mean (SD)	40.7 (11.9)
median [min, max]	39.0 [19.0, 70.0]
gender
female	532 (77.6%)
male	145 (21.1%)
non-binary	2 (0.3%)
other	3 (0.4%)
Missing	4 (0.6%)
race & ethnicity
asian	39 (5.7%)
black	151 (22.0%)
latinx/hispanic	85 (12.4%)
middle eastern	1 (0.1%)
mixed-race	14 (2.0%)
native american	2 (0.3%)
other	11 (1.6%)
person of color ‐ general	1 (0.1%)
prefer not to answer	20 (2.9%)
white	329 (48.0%)
Missing	33 (4.8%)
days in treatment
mean (SD)	96.8 (85.1)
median [min, max]	70.2 [0.0217, 335]
attended therapy session
no	30 (4.4%)
yes	656 (95.6%)
attended med. mgmt. session
no	561 (81.8%)
yes	125 (18.2%)
total therapy sessions | yes
mean (SD)	4.08 (3.77)
median [min, max]	3.00 [1.00, 32.0]
total med mgmt sessions | yes
mean (SD)	1.91 (1.42)
median [min, max]	1.00 [1.00, 8.00]
PHQ9 at baseline
mean (SD)	11.2 (6.32)
median [min, max]	10.0 [2.40, 27.0]
missing	191 (27.8%)
GAD7 at baseline
mean (SD)	9.70 (5.53)
median [min, max]	9.00 [1.48, 21.0]
missing	194 (28.3%)
Screened positive (≥10pts)
both PHQ & GAD	187 (27.3%)
GAD only	38 (5.5%)
PHQ only	80 (11.7%)
missing	381 (55.5%)
PHQ9 at baseline | positive
mean (SD)	16.0 (4.38)
median [min, max]	15.0 [10.0, 27.0]
missing	419 (61.1%)
GAD7 at baseline | positive
mean (SD)	14.9 (3.33)
median [min, max]	15.0 [10.0, 21.0]
missing	461 (67.2%)